Lasalocid, an ionophore coccidiostat, extensive use implies a risk of toxicological impacts. Protective effects of silybin, a herbal compound of Silybum marianum, are reported elsewhere. e aim of this study was to compare effects of the combined use of lasalocid and silybin in chicken hepatoma cells (LMH) and rat myoblasts (L6) cell lines cultures. e cytoprotective effect resulting from an interaction of both pharmaceuticals was measured with the help of MTT reduction and, coomassie brilliant blue binding (CBB) and LDH release assays. Isobolography and the combination index (CI) estimated the nature and scale of interaction. In all performed tests, the lowest lasalocid EC50-values were obtained for chicken hepatocytes. In the rat myoblasts cultures, the lowest lasalocid EC50-values were found with LDH test. Simultaneously, a lack of silybin cytotoxic effect was proven for the studied cell lines. An interaction between both substances led to a considerable decrease of lasalocid cytotoxicity. e isobolograms and combination index showed a signi�cant antagonistic nature of silybin effect in the course of lasalocid cytotoxicity. It is concluded that the mechanism of cytoprotection results from complex reaction at biochemical and biophysical endpoints during chicken hepatocytes and rat myoblasts cell lines exposure to silybin and lasalocid co-action.
Introduction
Lasalocid is a polyether carboxylic ionophorous antibiotic intended for use in the veterinary practice as a coccidiostat for the gastrointestinal parasites' treatment in poultry. is drug is characterized by a narrow safety margin, since the accidental lasalocid poisoning cases among animals have been reported [1] [2] [3] [4] . e clinical syndrome of lasalocid poisoning in animals includes skeletal muscle lesions, neurological signs, and increase serum enzymes,s which results from muscles and liver's damages [1] [2] [3] [4] . e toxicological monitoring of eggs and chicken edible tissues (liver, muscles) revealed that the concentration of lasalocid is much higher than its maximum residue limits (MRL) [5, 6] . In vitro studies report that lasalocid disturbs the ions membrane transport, leading to mitochondria damages and cell functioning [7] [8] [9] . In herbal medicine, milk thistle (Silybum marianum L. Gaertn.) is a plant with a well-recognized cytoprotective activity due to silymarin content. e extract from fruits and seeds of milk thistle consists of silybin, as a main �avonolignan, representing 50% to 70% of the silymarin content [10, 11] . Both in vitro and in vivo studies reported its cytoprotective, antioxidant, and chemopreventive properties. e hepatoprotective effect of silybin has been studied in chicken intoxications induced by toxic agents, such as acetaminophen, carbon tetrachloride, iron overload, amanita mushroom poisoning, or a�atoxicosis [12] [13] [14] . Recently, silybin found application in the cardiomyo-protective treatment [15, 16] . Results of silybin study indicated that its activity is expressed as a cell membrane stabilizer and permeability regulator. In addition, promotion of ribosomal RNA synthesis, free radicals scavenging, and regulation of intracellular content of glutathione by silybin have been reported [17] . However, there is limited information regarding silybin interaction with veterinary drugs.
e aim of this study is focused on lasalocid and silybin effects alone, followed by their combined simultaneous impact to liver and muscle cells, chicken hepatoma (LMH), and rat myoblast (L6) cell lines. Impact on the cell viability was examined by battery of tests, which evaluated the different endpoints at a cellular level. e MTT reduction to measure metabolism activity of living cells, coomassie brilliant blue dye (CBB) assay to evaluate total cellular protein, and lactate dehydrogenase release (LDH) to assess membrane stability tests were applied. e median effective concentrations (EC 50 ) were estimated separately for lasalocid and silybin, followed by their combined effects measurement. Presentation of the data on isobolograms and estimation of combination index (CI) allowed to understand the nature of lasalocid and silybin interaction and its scale.
Materials and Methods

Chemicals and
Reagents. e following chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA): silybin ≥98%, lasalocid sodium salt >97%, dimethyl sulfoxide (DMSO), 3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyl tetrazolium bromide (MTT), coomassie brilliant blue R-250 dye, Trixon X-100, trypsin-EDTA, fetal bovine serum (FBS), antibiotic solution (penicillin and streptomycin), and L-glutamine. Dulbecco's modi�ed Eagle media (DMEM) and Waymouth MB 751/1 were purchased from American Type Culture Collection (ATCC). All other chemicals were obtained from the commercial suppliers and were of the highest available purity.
Cell Cultures.
Chicken hepatoma cell line (LMH) (ATCC) and rat myoblasts cell line (L6) (ATCC) were cultured in DMEM and Waymouth MB 751/1, respectively. e mediums were supplemented with foetal bovine serum (10%), antibiotics, and L-glutamine. ose cells were cultured in 75 cm 2 cell culture �asks and kept at 5% CO 2 , 95% air, at 37 ○ C. e mediums were refreshed every 2 days and cells were trypsinized when they reached 70-80% con�uence. e cells were counted using Bürker's hemacytometer. e initial cell viability was determined with the trypan blue exclusion test. e cell suspensions were placed into 96-well plates (NUNC) at a density of 2 × 10 5 (LMH) and 2. [19] . e procedure was based on the INVITTOX Protocol no. 15 [20] .
2.6. LDH Assay. e lactate dehydrogenase release was determined by means of commercially available Cytotoxicity Detection Kit, LDH (Roche Diagnostics, Poland). e assay was applied to measure membrane integrity as a function of the amount of cytoplasmic LDH released into the medium. Wells with cells and culture medium with 2% Trixon X-100 were the positive control [21] .
Drug Interaction Analysis
. e nature of the interaction between the studied drugs was analysed with the help of isobolography according to Chou and Talaly method, which is based on the estimation of cytotoxic median effect (EC 50 ) [22] [23] [24] .
e LMH and L6 cells were simultaneously incubated for 24 h with lasalocid at a median effective concentration (EC 50 ) combined with silybin with the concentrations in the range from 1 to 250 M. Synergism or antagonism was depicted by the linear cell-kill effects obtained by the toxic drug in a combination with the interacting drug in the different concentrations [24] . e CI (combination index) mathematically compiled a two-drug pharmacological interaction and denominated its nature [22, 23] .
Statistical Analysis. e obtained results (percentage of
control values) are presented as mean values ± SD (standard deviation) of at least three independent experiments. ose data were assessed using one-way analysis of variance (ANOVA), then Dunnett post hoc test to determine the signi�cance relative to an unexposed control.
e concentrations necessary for 50% inhibition of viability of the cells for each substance (EC 50 ) were calculated. e statistical comparisons among EC 50 results were performed by an analysis of variance (ANOVA) followed by Tukey test. Differences were considered as statistically signi�cant at 0.05.
Results
Effects of Lasalocid on Chicken Hepatoma Cells (LMH) and Rat Myoblasts (L6)
. e cell metabolism, cellular protein content, and integrity of cell membrane were signi�cantly affected in a concentration-dependent manner aer 24 h exposure of chicken hepatocytes and rat myoblasts in the tested concentrations ranging from 1.0 to 250 M and compared to the control ones ( < 0.05) (Figure 1 ).
Lasalocid at concentrations above 10 M was cytotoxic for all chicken hepatocytes in performed three assays ( Figure  1 ).
Lasalocid at concentrations 1, 5, 10 M in rat myoblast cultures signi�cantly ( < 0.05) affected the integrity of cell membrane, cellular protein content, and cell metabolism, respectively ( Figure 1) .
e results of MTT, CBB, and LDH assays with lasalocid EC 50 in LMH and L-6 cell lines are shown in Table 1 . e mean values of effective concentrations of lasalocid in all assays with rat myoblasts were statistically different ( < 0.05), but it was not the case with chicken hepatocytes. e EC 50 values of lasalocid on chicken hepatocytes were at least twofold lower than those values on rat myoblasts with the exception of LDH test, where the values for lasalocid were at the same level in both cell lines (Table 1) .
Effects of Silybin on Chicken Hepatoma Cells (LMH) and Rat Myoblasts (L6).
Silybin at a concentration higher than 25, 50, and 100 M decreased cellular metabolism, cellular protein content, and integrity of the cell membrane in chicken hepatocytes, respectively ( < 0.05) (Figure 1 ).
Silybin at a concentration 100 M decreased metabolism and the cellular protein content in rat myoblasts. However, membrane integrity was affected at 10 M of the drug concentration; an increased LDH release was recorded at a signi�cant level (Figure 1) . e results of MTT, CBB, and LDH assays with silybin EC 50 in chicken and rat cells are shown in Table 1 . e EC 50 values for silybin in both cell lines were of one to two orders higher when compared to lasalocid EC 50 values. e EC 50 from MTT assay was signi�cantly ( < 0.05) lower than the values from EC 50 for CBB and LDH tests carried out with chicken hepatocytes (Table 1) . e EC 50 values of MTT assay with silybin on chicken cells were threefold lower than that value for the rat myoblasts, whereas CBB and LDH tests yielded EC 50 values at the same level on both cell lines (Table  1) . e mean values of effective concentrations of silybin in MTT, CBB, and LDH assays with myoblasts were statistically different ( < 0.05).
Effects Silybin on Cytotoxicity of Lasalocid on Chicken Hepatoma Cells (LMH) and Rat Myoblasts (L6).
Subsequent concentrations within 1-250 M range of silybin in co-action with lasalocid EC 50 tested by MTT, CBB, and LDH assays stemmed for an estimation of marked interaction scale (Table 1, Figure 1) . e values obtained for silybin in the interaction with lasalocid in MTT assay on chicken hepatocytes were signi�cantly lower, than the EC 50 estimated by use of CBB and LDH tests. e combined effect of both drugs yielded higher values than EC 50 values obtained for silybin acting alone in chicken hepatocytes and rat myoblasts, with an exception of the results of LDH assay in the rat cells cultures (Table 1) . e assays with rat myoblasts run for silybin in the interaction with lasalocid enabled to estimate EC 50 value only at LDH test.
3.4. e Nature of Interaction. e nature of the interaction between silybin and lasalocid in the chicken hepatocytes and rat myoblasts, analyzed with the help of isobolography, was depicted in Figure 2 . It shows an antagonistic character of the interaction that affects the cell metabolism, cellular protein content, and membrane integrity of chicken hepatocyte and rat myoblast cell-lines. An extent of the antagonistic interaction was shown by CI > 1, values which were obtained from the fractional cell-kill levels (Fa) at both culture cells (Figure 3) . e strong antagonistic effect of both compounds has been demonstrated for cellular metabolism and total protein contents in the hepatocytes. However, in the myoblasts the antagonistic effect of both interacting compounds was revealed for cellular membrane integrity and the total protein content. Antagonism was proven statistically, achieving combination index above 1 (CI > 1) at all tests assayed on chicken hepatocytes and rat myoblasts (Figure 3 ). e weak antagonism was noted at a higher concentration than 25 M of silybin coacting with lasalocid EC 50 at both cell lines (Figure 3 ).
Discussion and Conclusion
e conducted studies represent a preliminary in vitro investigation aiming to quantify the potentials for the coccidiostat and silybin interaction. In this study, we used cell lines derived from chicken hepatoma (LMH) and rat myoblasts (L6). e cell line cultures do not display all abilities of primary cell cultures, as the last ones retain more of physiological and biochemical functions. Nevertheless, the cell line cultures represent some good characteristics enabling to estimate a nature and a scale of cytotoxic effects. e cells are homogeneous and of long viability. Moreover, they allow to avoid preliminary step with animals keeping along with 3R rules. e LMH cell line was shown to possess a liver-like enzyme pattern including the enzymes involved in biotransformation [25, 26] .
Lasalocid's median effective concentration was determined in chicken hepatoma cells in order to �nd out the extend of the inhibition of cellular metabolism, decrease of the cellular protein content, and disintegration of cell membrane, which served as the basic cytotoxicity biomarkers. e inhibition of cells viability was found at rather low concentration of lasalocid, which indicates on its potential cytotoxicity. Our �ndings are in accordance with other studies carried out on different cultures. e results both from primary cells and cell lines assays proved that lasalocid causes a chain of cellular damages, which lead to the death of cells [8, [27] [28] [29] . e studies on FaO and HepG2 cell lines showed clearly that lasalocid toxicity targeted cell metabolism [29, 30] . e EC 50 of lasalocid MTT assay was found in range 4.0-9.0 M on rat (FaO) and human (HepG2) cell lines, which corresponds with EC50 for chicken cell lines (LMH). ese results suggest similar sensitivity of those metabolizing cells to the coccidiostat. e mechanism of lasalocid toxicity implies cytochrome P-450 microsomal enzymes involvement. eir catalytic activity can lead to formation of toxic metabolites, including the reactive and free radical derivatives of the coccidiostat [31] . Our results showed that chicken hepatocytes were more sensitive to the coccidiostat than rat myoblasts. It suggests that the role of lasalocid metabolites was involved in cytotoxicity. Myoblasts are the poor metabolizing cells and as a result EC 50 values were up to two times higher than at biochemically active chicken hepatocytes. e lower lasalocid EC 50 value of LDH test with myoblasts re�ected the toxicant targeting towards a membrane as the most sensitive endpoints of cell damage (Table 1) . e coccidiostat is responsible for changes in intracellular Ca 2+ level. e formation of complexes with cations leads to mediate their transport across the cell membrane in response to diffusion gradients. erefore, failures of ion pumps result in elevated intracellular sodium and calcium concentrations. Subsequently, mitochondrial swelling, metabolic disruption, and necrosis are developed [32] .
Detoxifying properties of the milk thistle (Silybum marianum L.) extracts are connected with silymarin, a mixture of �avonolignan compounds. Silybin, the ma�or constituent of silymarin, is a chemically standardized substance, which enabled its application in numerous in vivo and in vitro studies. All of them indicated a lack of silybin toxicity [29, [33] [34] [35] . e EC 50 for silybin was more than ten times higher than EC 50 for lasalocid in all endpoints tested. e literature data show that concentrations of silybin up to 100 M and longer exposure than 24 h led to apparent inhibition of cells growth; however, no cytotoxic effects were found [34] [35] [36] [37] . We showed that silybin in the concentrations lower than 100 M decreased cellular metabolism of chicken hepatocytes and increased the amount of LDH released from rat myoblasts. However, Chlopciková showed none cytotoxic effect of silybin on rat cardiomyocytes in concentration range 25-100 M and proved that the cardiomyocyte membranes are stabilized by silybin [16] . e mechanism of silybin effect may be explained by its hydrophobic character. is feature enables silybin penetration mainly to lipid bilayer component of the membrane leading to strengthen its biophysical structure. ese effects on membrane stabilization may correspond to the cell protection and lack of serious side effects aer the drug administration [38] . We have not found studies in the literature addressing the interaction of silybin with ionophore antibiotics. An interaction analyzed by Chou and Talalay method provided an assessment of cytotoxicity scale affected by combined use of silybin and lasalocid. It provided also an estimation of greater, equal, or smaller effects of lasalocid in coaction with silybin than for their action alone. Our study showed a decrease of lasalocid cytotoxicity aer its simultaneous exposure with silybin on both chicken hepatocytes and rat myoblasts. e data analyzed from Figure 1 and Table 1 proved a signi�cant interaction extent between those substances both on the chicken hepatocytes and rat myoblasts, which re�ected protective effect of silybin in course of lasalocid cytotoxicity. e EC 50 values obtained from MTT, CBB, and LDH assays analyzed by isobolograms showed antagonism of lasalocid and silybin interaction, which resulted in protection of cells derived from chicken liver. Furthermore, the EC 50 values from MTT and CBB assays with rat myoblasts were higher than the concentrations range of the drugs used in the assays with the hepatocytes. is implies different mechanisms of toxicity within the target cells and different antagonism scale between the studied drugs. Competitive bindings are probably involved in cytoprotective mechanisms of silybin and lasalocid interaction. If the components used as a mixture have different affinities towards the same binding site of the target cells, some of them could not be able to induce their toxicity. e antagonistic interactions were observed in cases of combination of silybin and phalloidin or ethanol [39] . e data of our previous studies have been shown an antagonistic interaction between lasalocid and silybin on rat (FaO) and human (HepG2) hepatoma cell lines. As a result of silybin interference a signi�cant decrease of lasalocid cytotoxicity was revealed in both cell cultures [29, 30] . Hepatocellular injury due to high level of lasalocid seems to be the primary event. It is a consequence of the drug action itself; however; the toxic metabolites are responsible for cellular damages, too [40] . Silybin displays a regulatory effect on cellular membrane permeability in association with an increase of membrane stability. It prevents against xenobiotics injury, as control of a toxin absorption into the cells by occupying the binding sites as well as inhibiting many transport proteins in the membrane is involved. Considering the protective properties of silybin, we should take into account its antioxidant effect, which could be particularly visible by metabolism stimulation in chicken hepatocytes. Silybin reduced cytotoxicity induced by benzo(a)pyrene, bleomycin, and a�atoxin B 1 [35] . Furthermore, silybin potentiated antitumor action of doxorubicin, cisplatin, carboplatin, and baicalein by synergistic effects leading to cell growth inhibition [37, 41] . e synergism or antagonism is probably an intricate balance between the concentration and type of antioxidants used, the class of chemotherapeutic agents administered, and the category of a cell involved [34] .
In general, it is difficult to clarify the full mechanisms underlying the effects of both drugs used in combination. It is possible that the interactions of silybin and lasalocid are because of some unknown mechanism related to complex perturbations of biochemical processes.
Nevertheless, the obtained results suggest in vivo interaction study when simultaneous presence of lasalocid and silybin in feeding is used. Hence, investigation on target animals can pose a rationale of therapy safety margin assessment and lasalocid residue tissue formation. Both issues are relevant to protection of animal welfare and public health. �on�ict of �nterests e authors declare that there is no con�ict of interests.
